JP2021527669A5 - - Google Patents
Info
- Publication number
- JP2021527669A5 JP2021527669A5 JP2020570744A JP2020570744A JP2021527669A5 JP 2021527669 A5 JP2021527669 A5 JP 2021527669A5 JP 2020570744 A JP2020570744 A JP 2020570744A JP 2020570744 A JP2020570744 A JP 2020570744A JP 2021527669 A5 JP2021527669 A5 JP 2021527669A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- composition
- salt
- acid entity
- entity
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687718P | 2018-06-20 | 2018-06-20 | |
| US62/687,718 | 2018-06-20 | ||
| US201862758174P | 2018-11-09 | 2018-11-09 | |
| US62/758,174 | 2018-11-09 | ||
| US201962794154P | 2019-01-18 | 2019-01-18 | |
| US62/794,154 | 2019-01-18 | ||
| PCT/US2019/038036 WO2019246298A1 (en) | 2018-06-20 | 2019-06-19 | Compositions and methods for the reduction or treatment of fibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527669A JP2021527669A (ja) | 2021-10-14 |
| JP2021527669A5 true JP2021527669A5 (https=) | 2022-09-02 |
| JPWO2019246298A5 JPWO2019246298A5 (https=) | 2022-09-02 |
Family
ID=67253997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570744A Withdrawn JP2021527669A (ja) | 2018-06-20 | 2019-06-19 | 線維症の軽減又は治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210275480A1 (https=) |
| EP (1) | EP3810272A1 (https=) |
| JP (1) | JP2021527669A (https=) |
| CN (1) | CN112839708A (https=) |
| MA (1) | MA52960A (https=) |
| WO (1) | WO2019246298A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| CN112823018A (zh) | 2018-06-20 | 2021-05-18 | 胺细拉健康公司 | 制备氨基酸组合物的方法 |
| WO2023009444A1 (en) * | 2021-07-26 | 2023-02-02 | Axcella Health Inc. | Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
| US9884899B2 (en) * | 2007-07-06 | 2018-02-06 | Promedior, Inc. | Methods for treating fibrosis using CRP antagonists |
| KR20090028880A (ko) * | 2007-09-17 | 2009-03-20 | 재단법인서울대학교산학협력재단 | 섬유증 예방 또는 치료용 약제학적 조성물 |
| US20150080320A1 (en) * | 2012-05-16 | 2015-03-19 | Aadigen, Llc | Multi-target modulation for treating fibrosis and inflammatory conditions |
| WO2015061607A1 (en) * | 2013-10-23 | 2015-04-30 | Whitehead Institute For Biomedical Research | Mtorc1 modulation by amino acids and uses thereof |
-
2019
- 2019-06-19 WO PCT/US2019/038036 patent/WO2019246298A1/en not_active Ceased
- 2019-06-19 MA MA052960A patent/MA52960A/fr unknown
- 2019-06-19 CN CN201980054596.4A patent/CN112839708A/zh active Pending
- 2019-06-19 JP JP2020570744A patent/JP2021527669A/ja not_active Withdrawn
- 2019-06-19 US US17/254,089 patent/US20210275480A1/en not_active Abandoned
- 2019-06-19 EP EP19739468.7A patent/EP3810272A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020504108A5 (https=) | ||
| CN110087647B (zh) | 氨基酸组合物及肝疾病的治疗方法 | |
| JP6482462B2 (ja) | 心房拡大又はリモデリングを特徴とする疾患を治療するためのｎｅｐ阻害剤 | |
| CN102625699B (zh) | 使用l-鸟氨酸苯乙酸盐治疗门静脉高压和恢复肝功能 | |
| AU2006320670B2 (en) | Methods for the treatment of muscle loss | |
| JP2021527669A5 (https=) | ||
| JP2023058496A (ja) | 肝疾患の治療のためのアミノ酸組成物 | |
| JP2021529736A5 (https=) | ||
| JP2004359663A (ja) | 尿酸を削減するためのヒスチジンおよびアラニンのジペプチドを含有する組成物およびそのジペプチドを用いる尿酸を削減するための方法 | |
| KR102567756B1 (ko) | 커큐민-펩타이드 컨쥬게이트 및 이의 제형 | |
| JP6151646B2 (ja) | 血管内皮機能低下の予防または改善剤 | |
| JP2021520358A (ja) | 虚血再灌流損傷を予防及び／又は治療する漢方薬組成物 | |
| JP5955499B2 (ja) | 皮膚コラーゲン産生促進剤 | |
| KR101342716B1 (ko) | 항-혈소판 약물, 영양 및 비타민 보충물로서의 아세틸화된아미노산 | |
| CN104546841A (zh) | 一种含有托匹司他的复方缓释制剂 | |
| JPWO2019246298A5 (https=) | ||
| CN112839708A (zh) | 用于减少或治疗纤维化的组合物和方法 | |
| JPWO2019246310A5 (https=) | ||
| JP3612729B2 (ja) | 滋養強壮剤 | |
| US11666643B1 (en) | Micronutrient combination to reduce blood pressure | |
| TWI694835B (zh) | 短胜肽用於治療/預防高血壓及其相關疾病之用途 | |
| JP2008208096A (ja) | クラゲタンパク質由来の新規ペプチドとその用途 | |
| CN109562149A (zh) | C1酯酶抑制剂的药物制剂 | |
| JPH04159219A (ja) | 腎不全用経口アミノ酸製剤 | |
| RU2809222C2 (ru) | Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия |